Rosen Law Firm Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
Image File
Original HTML

NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwit Connection, Inc. (NASDAQ: ELWT) resulting from allegations that Elauwit may have issued materially misleading business information to the investing public.

So what: If you purchased Elauwit securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

What to do next: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=55125 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

What is this about: On February 27, 2026, during market hours, Elauwit filed a Current Report with the Securities and Exchange Commission on Form 8-K announcing non-reliance on "previously issued interim financial statements included in the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, filed on December 10, 2025." The report stated "an error specific to network construction project revenue recognition during the first nine months of 2025," and the "restatement originates from work done by a third-party national accounting firm hired by the Company to assist in its accounting work prior to and immediately following its initial public offering; it did not involve any intentional misconduct with respect to the Company, its management or employees."

On this news, Elauwit's stock price fell $0.52 per share, or 6.8%, to close at $7.12 per share on March 2, 2026.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

[email protected]

www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

Share this article

Class (B2B/B2C)
Ignore
Ingest Status
Need Review
Dedupe hash
prn_302886773
Press Eligible
No
Press Eligible Reason
Irrelevant (need review): Law firm securities class action investigation and investor solicitation.
Source Name
Unknown Company
Original Summary

<p>NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwit Connection, Inc. (NASDAQ: ELWT) resulting from allegations that Elauwit may have issued materially...</p>

Image URL
https://mmx.prnewswire.com/media/MS1118010/Rosen-Law-Firm-Logo.jpg?id=OA2965026&p=facebook
Content Hash (SHA-256, erste 32 hex)
cce862228a11cc4971601fa630e748fc
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit
Image File
Original HTML

NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 16, 2026.

So what: If you purchased Doximity common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Doximity class action, go to https://rosenlegal.com/cases/doximity-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 16, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, Doximity overstated the impact that its Newsfeed would have on its revenue growth, and Doximity was losing market share to its competitors with more favorable pricing and engagement models, while also using banner ads and e-newsletters instead of deep engagement tactics. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Doximity class action, go to https://rosenlegal.com/cases/doximity-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.

     Phillip Kim, Esq.

     The Rosen Law Firm, P.A.

     275 Madison Avenue, 40th Floor

     New York, NY 10016

     Tel: (212) 686-1060

     Toll Free: (866) 767-3653

     Fax: (212) 202-3827

     [email protected]

     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

Share this article

Class (B2B/B2C)
Ignore
Ingest Status
Need Review
Dedupe hash
prn_302886777
Press Eligible
No
Press Eligible Reason
Irrelevant (need review): Law firm promotion for a securities fraud class action targeting Doximity investors.
Source Name
Unknown Company
Original Summary

<p>NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"). A...</p>

Image URL
https://mmx.prnewswire.com/media/MS1118010/Rosen-Law-Firm-Logo.jpg?id=OA2964882&p=facebook
Content Hash (SHA-256, erste 32 hex)
42133ec687ce56eda951282cd3b51075
Greenberg Traurig Adds Of Counsel Hayley Çapani to London Contentious Restructuring Team
Image File
Original HTML

LONDON, Sept. 22, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, LLP has added Hayley Çapani as of counsel to its London Litigation Practice, strengthening its contentious restructuring and insolvency capabilities and adding to the firm's Restructuring & Special Situations Practice. Çapani joins from Shoosmiths, where she established a strong market reputation among the insolvency practitioner community and co-led the firm's contentious insolvency practice.

Çapani advises companies, officeholders, financial institutions, and creditors on contentious restructuring and insolvency matters, with particular experience acting for different stakeholder groups in complex and cross-border disputes. Her work includes contested restructuring plans, directions applications, antecedent transaction claims, misfeasance claims, and disputes arising from formal insolvency proceedings across a range of sectors.

Masoud Zabeti, co-chair of the firm's Global Litigation Practice, said: "The intersection of litigation and restructuring is increasingly important to clients navigating complex and often cross-border situations. Hayley brings strong contentious insolvency experience and a track record of advising clients through challenging disputes and restructurings. Her arrival further strengthens our ability to bring together litigation, restructuring, and other capabilities to support clients on complex matters across jurisdictions."

Aaron Harlow, a London Restructuring & Insolvency Practice shareholder, added: "Hayley's contentious restructuring experience is highly complementary to our existing practice. She has advised a broad range of stakeholders on complex insolvency matters, including contested restructuring plans and cross-border disputes, and brings a strong understanding of the commercial issues that arise when restructuring situations become contentious. Having known Hayley for many years, I am looking forward to working closely with her as we continue to develop our restructuring and special situations offering in London."

The London Litigation Practice has recently received a number of industry recognitions, including Best Client Service Initiative at The Lawyer European Awards, Best Client Service at The Lawyer Awards, and Outstanding Collaboration at Law.com International's 2025 European Legal Innovation & Technology Awards. The firm's Restructuring & Special Situations Practice also has continued to expand its capabilities and market presence across Europe, the Middle East, and Africa (EMEA) regions, securing multiple top-five rankings in 9fin's European Restructuring and Liability Management Exercise league tables, and ranking among the top 10 firms for large-cap restructurings and the top five for mid-market restructurings in Octus' 2025 EMEA Restructuring Rankings for the third consecutive year. The practice is shortlisted for Restructuring Team of the Year at the 2026 Legal Business Awards for the second consecutive year.

Çapani said: "Greenberg Traurig's combination of a top-tier London litigation and arbitration practice, coupled with its impressive restructuring and special situations platform across EMEA, as can be seen from its strong performance in the latest 9fin and Octus rankings, was a key draw for me, as well as reuniting with Aaron, of course! I am excited to join such a highly regarded international team and contribute to its continued growth."

About Greenberg Traurig: Greenberg Traurig, LLP has approximately 3,200 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm's broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI "Best of the Best Recommended Law Firm" by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com.

SOURCE Greenberg Traurig, LLP

Share this article

Class (B2B/B2C)
Ignore
Ingest Status
Need Review
Dedupe hash
prn_302886713
Press Eligible
No
Press Eligible Reason
Irrelevant (need review): Law firm PR announcement about a personnel appointment.
Source Name
Unknown Company
Original Summary

<p>LONDON, Sept. 22, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, LLP has added Hayley Çapani as of counsel to its London Litigation Practice, strengthening its contentious restructuring and insolvency capabilities and adding to the firm's Restructuring & Special Situations...</p>

Image URL
https://mmx.prnewswire.com/media/MS1777985/Greenberg-Traurig-LLP-Logo.jpg?id=OA2964813&p=facebook
Content Hash (SHA-256, erste 32 hex)
d2d9d1a35d2b7d424af63759c8bd268b
LAWSUIT FILED: EXPEDIA/VRBO RENTS THOUSANDS OF PROPERTIES THAT VIOLATE ITS OWN FIRE-SAFETY RULES. DOMINICAN RENTAL FIRE KILLS 4 FROM MASSACHUSETTS FAMILY; SUIT ALLEGES SYSTEMIC PLATFORM FAILURE
Original HTML

LAWSUIT FILED: EXPEDIA/VRBO RENTS THOUSANDS OF PROPERTIES THAT VIOLATE ITS OWN FIRE-SAFETY RULES. DOMINICAN RENTAL FIRE KILLS 4 FROM MASSACHUSETTS FAMILY; SUIT ALLEGES SYSTEMIC PLATFORM FAILURE

SEATTLE, Sept. 22, 2026 /PRNewswire/ -- Families from Massachusetts affected by a deadly fire at a vacation rental in Barahona, Dominican Republic have filed a civil lawsuit in King County Superior Court against Expedia Inc., Expedia Group, Inc., HomeAway.com, Inc., and VRBO Holdings, Inc. Case #: 26-2-30948-5 SEA

This trip was meant to be a joyful family getaway and a chance for three generations to return to the Dominican Republic, the country of their birth, with the highlight being the christening of two young children. Instead, in the early morning hours of June 13, 2026, a fire engulfed the family's vacation rental. Four people died, including a five-year-old child, and other family members suffered severe and lasting injuries.

The Complaint alleges Defendants market their platform as safe and trustworthy, but do not enforce their own "Safety Essentials" instructions to hosts to install hardwired, interconnected smoke detectors outside all bedrooms and sleeping areas. VRBO's guest-facing "Our commitment to trust and safety" page makes no mention or warning of smoke alarms, carbon monoxide alarms, fire safety, or the platform's own safety essentials guidance.

It further alleges Defendants' booking and listing system was intentionally designed so that critical safety information (such as a host's self-disclosed "No smoke detector") is placed in a secondary "Safety" subsection, and the booking flow allows consumers to complete payment without being required to view or acknowledge that disclosure. The lawsuit alleges Defendants did not employ filters, warning banners, interstitial screens, or other meaningful point-of booking safety notices to alert travelers when a listing disclosed it lacked a smoke detector.

The Complaint also alleges this is not an isolated problem. VRBO continues to list thousands of accommodations for rent that it knows - because hosts have disclosed to VRBO - do not contain any smoke detectors. Forty days after the fire, Plaintiffs' counsel conducted searches of VRBO listings in multiple Dominican Republic locations and found that the vast majority of available properties did not list smoke detectors, indicating approximately 80% of listings reviewed were "potential death traps" with no smoke detectors. A follow-up search found that approximately 66% of listings reviewed still lacked smoke detectors.

A quote from Louis Farrah, Esq., attorney for the family: "A family of four is gone because an apartment was listed on the VRBO platform that had no smoke detectors, and Defendants knew it. That's not an accident. That's a choice made for profit, at the cost of four lives," said Louis J. Farrah, Esq., of Farrah Law, counsel for Plaintiffs. "And it hasn't stopped. Right now, VRBO has 2.5 million properties listed, and despite VRBO's "Safety Essentials" instructions to its hosts to install hardwired, interconnected smoke detectors outside all bedrooms and sleeping areas, VRBO continues to list thousands of accommodations for rent that it knows - because hosts have disclosed to VRBO - do not contain any smoke detectors. This family is fighting so that no other family has to bury someone they love because a company wouldn't make something as basic as a smoke detector a requirement to list a home."

About Farrah Law:

Farrah Law is a Boston trial firm representing plaintiffs in personal injury, wrongful death, and complex civil litigation matters in state and federal courts. With more than 60 years of combined experience, the firm's attorneys handle cases spanning motor vehicle and premises liability claims to commercial, real estate, and construction disputes. Led by attorneys Albert Farrah and Louis J. Farrah II, the firm is known for its client-focused approach and record of successful outcomes for injured individuals and their families. The firm is located on 100 Cambridge Street, Suite 2101, Boston, MA 02114. 

About Meehan Boyle, a Keches Law Firm:

Based in Boston, Meehan Boyle, a Keches Law Firm, is a premier litigation practice dedicated to advocating for victims of catastrophic personal injuries and wrongful death across Massachusetts. Established in 1985, the firm's seasoned litigators have recovered hundreds of millions of dollars via verdicts and legal settlements for injury victims and grieving loved ones, earning a distinguished reputation at the forefront of the commonwealth's legal community. Meehan Boyle operates out of 100 Cambridge Street, Suite 2101, Boston, MA 02114. For more information, visit www.meehanboyle.com/

Media Contact:

Victoria Tuttle, [email protected]; 978-618-1127

Attorneys for Plaintiffs: Albert Farrah and Louis J. Farrah, Farrah & Farrah, P.C. (Boston, MA) Leo V. Boyle, and Jeremy M. Carroll, Meehan Boyle, a Keches Law Firm (Boston, MA)

Local Co-Counsel: Maria Diamond, Diamond-Massong (Seattle, Washington)

SOURCE Keches Law Group P.C.

Share this article

Class (B2B/B2C)
Ignore
Ingest Status
Need Review
Dedupe hash
prn_302886830
Press Eligible
No
Press Eligible Reason
Irrelevant (need review): Law firm lawsuit announcement targeting companies and alleging systemic failure.
Source Name
LAWSUIT FILED
Original Summary

<p>SEATTLE, Sept. 22, 2026 /PRNewswire/ -- Families from Massachusetts affected by a deadly fire at a vacation rental in Barahona, Dominican Republic have filed a civil lawsuit in King County Superior Court against Expedia Inc., Expedia Group, Inc., HomeAway.com, Inc., and VRBO Holdings, Inc....</p>

Content Hash (SHA-256, erste 32 hex)
7f4a78d92b9b8f981d3702eb6f4e7382
The Princess Margaret Cancer Foundation Launches Historic $2.5 Billion Carry The Fire Campaign
Image File
Original HTML

The Princess Margaret receives a $100 million donation to mark the largest cancer fundraising campaign in Canadian history

TORONTO, Sept. 22, 2026 /PRNewswire/ -- The Princess Margaret Cancer Foundation has launched a historic $2.5 billion fundraising campaign to accelerate cancer research, treatment, and care at Princess Margaret Cancer Centre, strengthening Canada's position as a global leader in addressing one of the world's greatest scientific challenges and the leading cause of death in Canada.

The campaign has inspired a landmark $100 million gift from an anonymous donor with a personal connection to cancer. Compelled by that experience and The Princess Margaret's mission to create a world free from the fear of cancer, the donor made the largest gift ever received by The Princess Margaret Cancer Foundation. The gift will support the Princess Margaret Cancer Centre's highest-priority needs across research, education and care, providing the flexibility to accelerate breakthroughs and innovations when and where they are needed most. It is also the largest donation ever made toward cancer in Canadian history.

The launch comes at a defining moment for cancer research. Around the world, advances in artificial intelligence, genomics, precision medicine and cellular therapies are converging to create unprecedented opportunities to detect cancer earlier and to develop more effective, personalized treatments. Experts have described this period as the "golden age" of cancer research, a once-in-a-generation opportunity to transform patient outcomes.

"The Princess Margaret is not just participating in the global cancer ecosystem; it is shaping the model others will follow," said Dr. Miyo Yamashita, President and CEO of The Princess Margaret Cancer Foundation. "This is a moment of real opportunity, and we can meet this challenge. The Princess Margaret has the talent, the model, and, with the driving support of philanthropy, the momentum. Every breakthrough brings us closer to a future where fewer families fear the words no one ever wants to hear, 'You have cancer.' Now is the moment to come together and help create a world free from the fear of cancer."

The $2.5 billion campaign will focus philanthropic investment across three strategic priorities that have the potential to redefine the future of cancer care here in Canada and around the world.

Stage 0: Catching cancer at its earliest stages and finding it before it becomes life-threatening.

Beyond Chemotherapy: Advancing new approaches to cancer treatment, including precision medicine, immunotherapy, theranostics, genomics and AI-enabled care, to deliver more effective, personalized treatments with fewer side effects.

Boundless Cancer Care: transforming the cancer experience for patients and loved ones through survivorship, rehabilitation, mental health resources, and holistic support.

Together, these priorities reflect a broader ambition: to ensure Canada is not simply participating in the future of cancer research but defining it.

"Princess Margaret is one of the places where the future of cancer care is being created," said Dr. Kevin Smith, President and CEO of University Health Network. "Across UHN, we have the extraordinary combination of clinical expertise, scientific discovery, innovation and education needed to move breakthroughs from the laboratory to the bedside—and ultimately change what is possible for patients. Carry The Fire will help us accelerate that work, extend its impact and continue pushing the boundaries of cancer care for patients in Canada and around the world."

With a deeply collaborative global research network and one of the most diverse patient populations in the world, The Princess Margaret produces deeper biological insights, more robust clinical data, and discoveries that are applicable across populations and over 200 cancer types.

"Carry The Fire is about more than a fundraising campaign; it is a movement that will shape what becomes possible for people affected by cancer," said Janice Fukakusa, Campaign Cabinet Co-Chair. "We have an opportunity to accelerate breakthroughs that will change lives here at home and around the world. That's why I'm proud to stand behind this campaign and invite others to be part of this defining moment, and I am deeply grateful to all of the donors and supporters, including the visionary philanthropist whose extraordinary $100 million gift, the largest in our history, was entrusted to the Cancer Centre's highest priorities. That remarkable act of generosity reflects the profound confidence our community has in this organization and the impact we can achieve together."

ABOUT THE PRINCESS MARGARET CANCER FOUNDATION

The Princess Margaret Cancer Foundation is Canada's largest cancer charity. We're dedicated to raising funds for Princess Margaret Cancer Centre, one of the world's leading cancer research and treatment centres, known for its breakthrough discoveries that transform patient outcomes. Together, our work benefits cancer patients everywhere in our mission to create a world free from the fear of cancer. Through philanthropy, fundraising events, and our world-leading lottery program, we're changing how the world understands, prevents, diagnoses, and treats cancer, benefiting patients at The Princess Margaret, throughout Canada, and around the world.

SOURCE Princess Margaret Cancer Foundation

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302886726
Press Eligible
Yes
Press Eligible Reason
Healthcare foundation launches a major cancer research and care fundraising campaign, including a record donation and technology-focused priorities.
Source Name
Unknown Company
Original Summary

<p>The Princess Margaret receives a $100 million donation to mark the largest cancer fundraising campaign in Canadian history TORONTO, Sept. 22, 2026 /PRNewswire/ -- The Princess Margaret Cancer Foundation has launched a historic $2.5 billion fundraising campaign to accelerate cancer...</p>

Image URL
https://mmx.prnewswire.com/media/MS1762397/Princess-Margaret-Cancer-Foundation-The-Princess-Margaret-Cancer.jpg?id=OA2964693&p=facebook
Content Hash (SHA-256, erste 32 hex)
62b305139a0933802e2c8380aa9dd2d1
CJ 4DPLEX EXPANDS SCREENX PRESENCE IN EUROPE THROUGH NEW AGREEMENT WITH PATHÉ CINÉMAS
Image File
Original HTML

CJ 4DPLEX EXPANDS SCREENX PRESENCE IN EUROPE THROUGH NEW AGREEMENT WITH PATHÉ CINÉMAS

Partnership marks a major SCREENX milestone with one of Europe's most prominent cinema exhibitors

BURBANK, Calif., Sept. 22, 2026 /PRNewswire/ -- CJ 4DPLEX, the world's leading producer of premium cinema formats and immersive theater experiences, and Pathé Cinémas, one of Europe's leading cinema operators, today announced a new agreement to bring four new SCREENX auditoriums to France, Belgium, and the Netherlands. Two locations in Belgium, one in France and one in the Netherlands are set to open by the end of 2026.

The agreement builds on a longstanding relationship between CJ 4DPLEX and Pathé Cinémas. What began with the introduction of multisensory 4DX to European audiences evolved to include the launch of SCREENX at Pathé La Villette in Paris in 2018. Adding four new SCREENX locations across France, Belgium, and the Netherlands represents the next phase of that partnership and reflects both companies' ongoing commitment to premium cinema experiences in Europe.

Pathé Cinémas is one of Europe's most notable cinema exhibition companies. The company has played a defining role in shaping modern moviegoing in France, with operations also spanning Belgium, the Netherlands, Switzerland, Tunisia, Côte d'Ivoire, Senegal, and Morocco. Pathé Cinémas remains a central force in European film production and distribution through its broader entertainment business.

SCREENX transforms the moviegoing experience with its revolutionary format, which seamlessly extends the picture beyond the front screen and onto the auditorium's surrounding walls on the left and right sides. Delivering this premium 270-degree panoramic display enhances key scenes with exclusive visual elements and fully immerses audiences in a one-of-a-kind cinematic adventure.

"Europe is one of SCREENX's most dynamic and strategically important markets, and this expanded agreement with Pathé Cinémas represents another significant milestone in our growth," said Don Savant, Chief Business Officer, CJ 4DPLEX. "Pathé is one of Europe's most respected and innovative cinema exhibitors, and we are proud to deepen our longstanding partnership across France, Belgium, and the Netherlands. Together, we look forward to bringing the uniquely immersive SCREENX experience to more moviegoers and creating new opportunities to expand our partnership throughout Europe."

"Our relationship with CJ 4DPLEX has been built on a shared belief in the power of premium cinema, and this expansion deal follows naturally from that foundation," said Laure de Boissard, Managing Director of Pathé Cinemas. "Bringing SCREENX to additional markets across Europe is an exciting step, and we look forward to offering our guests a premium experience that goes beyond the traditional screen."

Together, the four auditoriums will further establish SCREENX's presence across three of Europe's most active cinema markets.

About Pathé Cinémas

Pathé is the leading cinema operator in France, the Netherlands, and Switzerland, and also operates in Belgium, Tunisia, Côte d'Ivoire, Senegal, and Morocco. Pathé operates 129 cinemas with a total of 1,308 screens. Its strategy of moving upmarket and modernizing its cinemas is driven by an active policy of building, rebuilding, and renovating; continuous innovation featuring the best technologies; unique, tailored services; and an optimized moviegoer experience, both in-cinema and online.

About CJ 4DPLEX

CJ 4DPLEX is a proud subsidiary of CJ Group, Korea's leading lifestyle and culture company. Headquartered in Sangam, Seoul, we design and develop immersive cinema technologies that inspire audiences worldwide. Guided by creativity, technology, and cultural vision, we are committed to redefining the future of cinema starting right here in Korea.

CJ 4DPLEX is redefining the moviegoing experience across many countries worldwide, working with the world's top exhibitors to deliver SCREENX, 4DX and ULTRA 4DX to audiences everywhere. From the United States to Europe, Asia, and the Middle East, our global presence keeps growing driven by our mission to make immersive storytelling the standard in cinema. Innovation drives us to connect people beyond language and borders through shared experiences.

About SCREENX

SCREENX is the world's most immersive platform, breaking free from the boundaries of a single screen to place audiences at the heart of the story. With visuals flowing seamlessly across the walls, SCREENX connects film and space, creating moments of true natural immersion. Every sequence is curated to reflect the director's vision, turning each film into a journey only SCREENX can deliver.

About 4DX

4DX provides the best synesthetic viewing experience that connects the audience with movies through its state-of-the art motion-seats and 21 environmental effects that include water, wind and scents. The 4DX theater is a special theater where you can feel various environmental effects such as wind, light, fog, fragrance, and vibration, as well as motion chairs that move according to the scene of the movie. Audiences can feel a new level of 4DX effect that maximizes vividness in each scene beyond simply watching movies with limitations of existing video and sound.

SOURCE CJ 4DPLEX

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302886809
Press Eligible
Yes
Press Eligible Reason
Business partnership expanding premium cinema technology across European theaters.
Source Name
Unknown Company
Original Summary

<p>Partnership marks a major SCREENX milestone with one of Europe's most prominent cinema exhibitors BURBANK, Calif., Sept. 22, 2026 /PRNewswire/ -- CJ 4DPLEX, the world's leading producer of premium cinema formats and immersive theater experiences, and Pathé Cinémas, one of Europe's leading...</p>

Image URL
https://mmx.prnewswire.com/media/MS1350627/CJ-4DPLEX-Logo.jpg?id=OA2964833&p=facebook
Content Hash (SHA-256, erste 32 hex)
c8969a00a62884603a290ebfe75136c9
Pentair Deadline: PNR Investors Have Opportunity to Lead Pentair plc Securities Fraud Lawsuit
Image File
Original HTML

NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of Pentair plc (NYSE: PNR) between March 11, 2025 and July 14, 2026, inclusive (the "Class Period"), of the important October 2, 2026 lead plaintiff deadline.

So what: If you purchased Pentair securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Pentair class action, go to https://rosenlegal.com/cases/pentair-plc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 2, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made materially false and/or misleading statements and or failed to disclose that: (1) Pentair's 80/20 program had failed to improve Pentair's business and operations and had instead materially impaired Pentair's longstanding commercial relationships, alienated its customers, and created widespread customer dissatisfaction, particularly within Pentair's Pool segment; (2) Pentair was losing business and market share, as a significant portion of its Pool customers had turned to competitors in response to Pentair's 80/20 program initiatives, which had more than offset any purported benefits to Pentair's business and financial results as a result of the implementation of the 80/20 program; (3) Pentair's implementation of the 80/20 program had caused certain of its remaining Pool customers to buy inventory in excess of their current needs in advance of future price increases, cannibalizing Pentair's future sales; (4) Pentair's remaining Pool customers had received rebates at rates above historical norms, which had artificially inflated Pentair's sales and revenue in the short-term at the expense of future periods; and (5) as a result of the above, Pentair was acutely exposed to material, undisclosed risks of significant financial and operational harms as a result of Pentair's implementation of its 80/20 program. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Pentair class action, go to https://rosenlegal.com/cases/pentair-plc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.

     Phillip Kim, Esq.

     The Rosen Law Firm, P.A.

     275 Madison Avenue, 40th Floor

     New York, NY 10016

     Tel: (212) 686-1060

     Toll Free: (866) 767-3653

     Fax: (212) 202-3827

     [email protected]

     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

Share this article

Class (B2B/B2C)
Ignore
Ingest Status
Need Review
Dedupe hash
prn_302886772
Press Eligible
No
Press Eligible Reason
Irrelevant (need review): Law firm securities fraud class action solicitation targeting Pentair investors.
Source Name
Pentair Deadline
Original Summary

<p>NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of ordinary shares of Pentair plc (NYSE: PNR) between March 11, 2025 and July 14, 2026, inclusive (the "Class Period"), of the important October 2, 2026 lead plaintiff...</p>

Image URL
https://mmx.prnewswire.com/media/MS1118010/Rosen-Law-Firm-Logo.jpg?id=OA2964957&p=facebook
Content Hash (SHA-256, erste 32 hex)
964fcc77d8eac865843f67a12ba93c78
A Game Changer: Harold Hamm Commits Largest Gift in OU History to Lift Health of Oklahoma, Name Health Campus
Image File
Original HTML

OKLAHOMA CITY, Sept. 22, 2026 /PRNewswire/ -- The University of Oklahoma today announced an historic $150 million gift from Harold Hamm, the largest single gift in university history, to lift the health of Oklahoma by advancing health education, research and discovery, strengthening the state's health care workforce and accelerating the pursuit of breakthroughs against Oklahoma's critical public health challenges.

In recognition of Hamm's extraordinary generosity and the lasting impact of his vision, OU's Health Campus in Oklahoma City will be named the Harold Hamm Health Campus at the University of Oklahoma.

The gift makes Hamm the largest individual donor in OU history, with his lifetime giving to the university approaching $250 million. Of the $150 million commitment, $50 million will advance the next era of research and discovery at the Harold Hamm Diabetes Center, while $100 million will advance the broader academic and research enterprise of the Health Campus.

"Harold Hamm is a global visionary who has spent his life seeing what is possible and having the courage to act on it," said OU President Joseph Harroz Jr. "His remarkable story embodies the American Dream, and the ambition and determination that define Oklahoma. Today, he sees a university, a state and a community that have built the people, partnerships and capacity to change the trajectory of health in Oklahoma. This gift is about far more than its historic size. It is Harold's belief in what is now possible and an invitation to all of us to seize this moment and improve lives for generations to come."

A Moment Decades in the Making

Hamm's investment comes at a pivotal moment for health in Oklahoma. The state continues to face significant health challenges and an urgent need for more health professionals. At the same time, over the past several years, growing investment and alignment among OU, the state of Oklahoma, federal leaders and agencies, tribal nations, philanthropy, health care partners and others have strengthened an academic health system with greater capacity than ever before to confront those challenges.

The Harold Hamm Health Campus brings together six health professions colleges and the university's Graduate College, more than 4,100 students, along with a growing community of researchers, educators and clinicians. The campus educates 80% of Oklahoma's health care workforce, while its research enterprise has grown rapidly and this year earned Oklahoma's first-ever Top 100 national ranking in National Institutes of Health funding.

OU is building on that momentum through Project 200, its effort to recruit more than 200 world-class researchers in areas where discovery can have an outsized impact on Oklahoma and the nation. Health is one of Project 200's four major areas of focus, with 150 health campus researchers being recruited in diabetes and metabolic disease, cancer, neuroscience and other fields with the potential to prevent disease, ease suffering and save lives.

That growing strength in education and research is closely connected to the third component of Oklahoma's academic health system: patient care. OU Health, the university's clinical partner, recently celebrated its fifth anniversary following one of the most remarkable academic health system turnarounds in the country. Today, OU Health serves more than 1 million patient visits annually and has significantly expanded access to specialty and subspecialty care across Oklahoma. As OU recruits leading scientists and physician-scientists, their research can create new opportunities for clinical trials, treatments and other advances for patients whose conditions require the highest levels of specialized expertise and care.

"Our goal is simple: turn what we learn in the research lab into better care at the bedside," said Jonathan W. Curtright, MBA, MHA, president and CEO of OU Health. "Bringing more leading researchers and physician-scientists to Oklahoma through Project 200 means more clinical trials, new treatments and the latest discoveries reaching our patients sooner. Harold Hamm's investment will accelerate that work for Oklahomans."

A Vision for Changing Lives

It is that convergence – profound need coupled with growing capacity to address it – that Hamm sees as an opportunity to change the game.

Throughout his career, Hamm has taken on consequential challenges where he believed bold action could make a meaningful difference in people's lives. From his pioneering work in American energy to his advocacy for affordable insulin, his approach has remained consistent: recognize an opportunity others may not yet see, bring together the people and resources necessary to pursue it, and act.

His nearly two-decade commitment to fighting diabetes offers one of the clearest examples.

After being diagnosed with Type 2 diabetes in his 50s, Hamm turned his attention to a disease that affects hundreds of thousands of Oklahomans. In 2007, his lead gift helped establish the OU Health Harold Hamm Diabetes Center around an ambitious goal: improve the lives of people with diabetes while pursuing the discoveries that could ultimately lead to a cure.

Since then, Hamm has invested more than $50 million in that effort, helping OU recruit leading scientists and build the technology and infrastructure needed to pursue breakthrough research. NIH research dollars at OU associated with the diabetes center has grown from $5 million to $33 million since its founding, significantly expanding its research capacity.

Hamm also established the Harold Hamm International Prize for Biomedical Research in Diabetes, the world's largest international prize of its kind and widely regarded as the "Nobel Prize" of diabetes research.

Beyond the laboratory, Hamm took his fight against diabetes to Washington, advocating for more affordable and accessible insulin and providing leadership and vision in support of the Affordable Insulin Now Act, which sought to cap patients' out-of-pocket insulin costs at $35 per month.

His involvement has extended to recruiting the scientists who will lead the next phase of research and healing.

This month, world-renowned translational scientist John P. Kirwan, Ph.D., joined OU as executive director of the Harold Hamm Diabetes Center, vice provost for diabetes programs and Chickasaw Nation Endowed Chair in Diabetes Research. Kirwan's recruitment through Project 200 reflects the scale of OU's ambitions: bringing leading researchers to Oklahoma who can build teams, attract additional research investment and move discoveries toward new treatments and cures.

"The Harold Hamm Diabetes Center was built on the belief that bringing together the best minds and giving them the resources to pursue bold ideas can change lives and ultimately cure diabetes," Hamm said earlier this year in announcing Kirwan's recruitment. "We've come a long way in our fight against diabetes, but I believe our most important discoveries are still ahead of us."

Of Hamm's new $50 million investment in the center, $30 million will support Dr. Kirwan and his priorities in advancing the HHDC, while $20 million will support capital improvements and research infrastructure. Together, those investments are intended to accelerate research aimed at preventing and treating diabetes, reducing its devastating complications and ultimately finding a cure.

"The greatest things this country has ever accomplished started with people willing to believe something better was possible — and then willing to do the work to make it happen. I've spent my life believing that when you see an opportunity to change the future, you don't stand on the sidelines — you act. Oklahoma has given me more than I could ever repay, and I can think of no greater investment than in the health and lives of its people," Hamm said. "We have an extraordinary opportunity right now to bring the very best minds in medicine and science to Oklahoma, give them the resources to pursue discoveries that once seemed impossible, and build something here that can change lives far beyond our state. My hope is that this gift will help make Oklahoma a place where the next great medical breakthrough happens — where diseases are prevented, lives are saved and, one day, diseases like diabetes are cured. That is a legacy worth building."

Building What Comes Next

The remaining $100 million will extend that same ambition across the Harold Hamm Health Campus – helping OU educate more of the health professionals Oklahoma urgently needs, recruit leading researchers and give them the tools and infrastructure to pursue discoveries that can improve and save lives.

The investment builds on significant momentum. OU's overall research activity has increased more than 70% over the past six years, while the Health Campus has experienced record enrollment growth and surpassed 4,000 students for the first time. This year, the Health Campus earned its first-ever Top 100 ranking in NIH funding, placing it among the top 4% of institutions nationwide that receive NIH support, according to the Blue Ridge Institute for Medical Research.

For Hamm, that progress – and the collective investment behind it – helped create the opportunity he sees today.

The naming of the Harold Hamm Health Campus recognizes his extraordinary lifetime impact on OU, but his latest commitment is intended to do more than commemorate what has already been accomplished. It is designed to accelerate what comes next – and serve as a catalyst for others who share the belief that Oklahoma's health challenges do not have to define its future.

"This is a moment decades in the making," said Gary Raskob, Ph.D., senior vice president and provost of the Harold Hamm Health Campus. "Harold's investment builds on the commitment of countless people and partners who have helped strengthen health education, research and patient care in Oklahoma.

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302886804
Press Eligible
Yes
Press Eligible Reason
QA FAIL (need review): TARGET says the Affordable Insulin Now Act 'capped' insulin costs at $35/month, but SOURCE only says the Act 'sought to cap' those costs. This misstates the legislative status and is an unsupported factual claim.
Source Name
A Game Changer
Original Summary

<p>OKLAHOMA CITY, Sept. 22, 2026 /PRNewswire/ -- The University of Oklahoma today announced an historic $150 million gift from Harold Hamm, the largest single gift in university history, to lift the health of Oklahoma by advancing health education, research and discovery, strengthening the...</p>

Image URL
https://mmx.prnewswire.com/media/MS1994395/University-of-Oklahoma.jpg?id=OA2965156&p=facebook
Content Hash (SHA-256, erste 32 hex)
cec5625711c55431cdfdc7dd95b4cdd9
Nutex Health Approved for Dual Listing on Nasdaq Texas
Original HTML

Nutex Health Approved for Dual Listing on Nasdaq Texas

HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX) today announced that it has received approval to dual-list its common stock on Nasdaq Texas. Nutex Health is a physician-led, healthcare services and operations company with 28 hospital facilities in 12 states, and a primary care-centric, risk-bearing physician network.

Trading on the Nasdaq Texas venue is expected to commence at the market open on or about Sept. 23, 2026.

The Company's common stock will continue to trade on the Nasdaq Global Market under its current ticker symbol, "NUTX." The dual listing does not require any action by existing stockholders, and shares of common stock will remain fully fungible across both trading venues.

"We are incredibly proud to establish a trading presence on Nasdaq Texas," said Tom Vo, M.D., MBA, Chairman and CEO of Nutex Health Inc. "With our senior leadership and corporate headquarters firmly anchored in the Houston metropolitan area, this expands our visibility among regional institutional investors while maintaining the national and international presence of our primary Nasdaq market."

In connection with the dual listing, the Company has filed a registration statement on Form 8-A with the U.S. Securities and Exchange Commission (SEC) under Section 12(b) of the Securities Exchange Act of 1934.

About Nutex Health Inc.

Headquartered in Houston, Texas, and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a healthcare management and operations company with three divisions: a Hospital Division, Population Health Management Division, and Real Estate Division.

The Hospital Division owns, develops, and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 28 facilities in 12 states.

The Population Health Management division owns and operates provider networks such as Independent Physician Associations. Through our Management Services Organization, we provide management, administrative, and other support services to our affiliated hospitals and physician groups.

The Real Estate division comprises real estate entities along with activities related to the development and construction of hospital facilities. The real estate entities own the land and hospital buildings which are leased to our hospital entities.

Forward-Looking Statements

Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words or phrases "will," "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, regulatory and litigation uncertainty under the No Surprises Act, lawsuits filed by health insurance providers against our third-party provider in the arbitration process, sales of a substantial amount of our Common Stock by our stockholders, our obligation to issue additional shares of our common stock to former doctor owners of under construction hospitals, manipulative short seller reports, the impact of litigation and disputes, our ability to successfully execute our growth strategy, economic conditions, dependence on management, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent Quarterly Reports on Form 10-Q for the three months ended March 31, 2026 and the six months ended June 30, 2026, under the heading "Risk Factors" in Part II, Item IA thereof, and the risk factors and other cautionary statements contained in our other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

SOURCE Nutex Health, Inc.

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302886808
Press Eligible
Yes
Press Eligible Reason
Corporate healthcare company announces approval for a Nasdaq Texas dual listing, a relevant capital markets and business development update.
Source Name
Unknown Company
Original Summary

<p>HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX) today announced that it has received approval to dual-list its common stock on Nasdaq Texas. Nutex Health is a physician-led, healthcare services and operations company with 28...</p>

Content Hash (SHA-256, erste 32 hex)
1dc3b53e9438c69a9c11917bbba0ff0e
Islanders Co-Owner Jon Ledecky Visits LIU, Named "Honorary Captain" of LIU Hockey
Image File
Original HTML

BROOKVILLE, N.Y., Sept. 22, 2026 /PRNewswire/ -- Long Island University welcomed New York Islanders Co-Owner Jon Ledecky to campus today as part of the University's Centennial CEO Speaker Series, bringing hundreds of LIU students together for a conversation on leadership, career development and the business of professional sports.

Ledecky shared his career trajectory, lessons on leadership and his innovative approach to leading the New York Islanders. The conversation was moderated by LIU alumnus and ESPN personality Alan Hahn and concluded with a student question-and-answer session.

"Our partnership with the New York Islanders and UBS Arena is creating extraordinary opportunities for our students," said LIU President Kimberly R. Cline. "Welcoming Jon Ledecky to campus to share his leadership and experience is a great example of that partnership in action."

Ledecky was introduced by the captains of LIU's Division I men's and women's ice hockey teams. Following the program, LIU student-athletes presented him with a personalized LIU Sharks jersey and named him Honorary Captain of LIU Hockey for the 2026–27 season.

"This was a unique opportunity for our students to learn directly from a leader at the highest levels of sports and business," said LIU Women's Ice Hockey Head Coach Kelly Nash. "These are the experiences that make an LIU education so special."

Ledecky's visit builds on the five-year strategic partnership announced earlier this year between Long Island University, the New York Islanders and UBS Arena to advance the growth and development of hockey throughout Long Island and New York City.

LIU is home to the only NCAA Division I men's and women's ice hockey programs in the New York City and Long Island region, with both teams playing their home games at Northwell Health Ice Center, the official practice facility of the New York Islanders. LIU maintains permanent, state-of-the-art facilities at the arena, including dedicated locker rooms, coaching offices and player spaces for its Division I hockey programs.

"Long Island is a hockey community, and LIU is proud to represent this region at the Division I level," said LIU Men's Ice Hockey Head Coach Brendan Riley. "Having Jon on campus shows the strength of our partnership with the Islanders and our shared commitment to growing the game."

A centerpiece of the partnership is the Empire State Holiday Invitational, an annual Division I men's hockey tournament at UBS Arena. LIU will serve as the host institution and compete in the tournament each year, with the inaugural event scheduled for December 28–29, 2026.

The partnership also extends beyond competition. LIU supports the Islanders' Learn to Play program, which introduces children throughout the region to hockey, while LIU students gain expanded opportunities for experiences with the Islanders, UBS Arena and leaders across the sports and entertainment industries.

The Centennial CEO Speaker Series is part of Long Island University's yearlong celebration of its 100th anniversary, bringing prominent business leaders, entrepreneurs and innovators to campus to share their experiences and insights with the next generation of leaders.

About Long Island University

Long Island University, founded in 1926, is a leading research and teaching university that continues to redefine higher education by providing high-quality academic instruction by world-class faculty, serving more than 16,000 students from its Long Island and Brooklyn campuses. Recognized by Forbes for its emphasis on experiential learning and by the Brookings Institution for its "value added" to student outcomes, the University is ranked in the top 7% of national research universities. LIU has a network of over 285,000 alumni, including industry leaders and entrepreneurs around the globe. Visit www.liu.edu for more information

About the New York Islanders

The New York Islanders Hockey Club is the proud winner of four Stanley Cup Championships and record nineteen consecutive playoff series victories. The Islanders play in the National Hockey League's Eastern Conference, and have eight players, two general managers and one coach inducted into the Hockey Hall of Fame.

The Islanders Children's Foundation has helped countless youngsters in need around the world since its inception. Donations are raised through the efforts of our players, management, and employees, along with our fans and partners.

UBS Arena is the team's state-of-the-art home and features world class premium hospitality, great sightlines from every seat, and a loud and intimate bowl. Isles Lab, the official team store of the New York Islanders, offers fans traditional NHL merchandise, unique collaborations and exclusive products. Isles Lab is located inside UBS Arena or can be shopped online at IslesLab.com.

SOURCE Long Island University

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Rewritten
Dedupe hash
prn_302886790
Press Eligible
Yes
Press Eligible Reason
Business and education partnership featuring a professional sports executive, leadership discussion, and industry collaboration.
Source Name
Unknown Company
Original Summary

<p>BROOKVILLE, N.Y., Sept. 22, 2026 /PRNewswire/ -- Long Island University welcomed New York Islanders Co-Owner Jon Ledecky to campus today as part of the University's Centennial CEO Speaker Series, bringing hundreds of LIU students together for a conversation on leadership, career...</p>

Image URL
https://mmx.prnewswire.com/media/MS1994359/Long-Island-University-x-Jon-Ledecky.jpg?id=OA2965011&p=facebook
Content Hash (SHA-256, erste 32 hex)
0337a16866669b056c58f1772b2d11d1